BiotechTube
Home/Lundbeck/Johan Luthman
JL

Johan Luthman

Executive Vice President, Head of Research & Development

Lundbeck

Therapeutic Areas

PsychiatryNeurologyNeuro-rare Diseases

Lundbeck Pipeline

DrugIndicationPhase
Lu AG09222 (mAb)Migraine PreventionPhase 2
Lu AG06466Parkinson's Disease PsychosisPhase 2
Lu AG13909SchizophreniaPhase 1
Lu AG09222Post-Traumatic Stress Disorder (PTSD)Phase 2

Leadership Team at Lundbeck

TG
Thomas Gibbs
Executive Vice President and President, Lundbeck North America
CV
Charl van Zyl
Executive Vice President, Head of Europe & International Markets
View full Lundbeck profile